• Privacy Policy
  • Terms Of Service
  • Facebook
  • Twitter
  • LinkedIn
  • Instagram
Forex trading, free forex education | Forex.ca

 

  • Home
  • Forex News
  • Stock News
  • For Beginners
  • Market Analysis
  • Trading Strategies
  • Real Time Stock Update
  • Shop
News Ticker
  • [ September 30, 2025 ] Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders Stock News
  • [ September 30, 2025 ] Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary Stock News
  • [ September 30, 2025 ] Tesla (TSLA) Share Price Rises Ahead of Earnings Report Forex News
  • [ September 29, 2025 ] Accenture: The Best Way To Play AI's Next Phase Stock News
  • [ September 29, 2025 ] Growth & Total Return Weekly Chat Stock News
Home2022

Year: 2022

Stock News

fuboTV Stock Tumbles 17% on Guidance Cut, Earns Two Downgrades By Investing.com

May 6, 2022 admin 0

© Reuters. fuboTV (FUBO) Stock Tumbles 17% on Guidance Cut, Earns Two Downgrades Shares of FuboTV (NYSE:) are down more than 17% in premarket trading Friday after the streaming television service provider trimmed its NA […]

Stock News

U.S. elections may thwart Democratic effort to cap insulin cost By Reuters

May 6, 2022 admin 0

3/3 © Reuters. FILE PHOTO: Boxes of the drug NovoLog, made by Novo Nordisk Pharmaceutical, sit on a counter at a pharmacy in Provo, Utah, U.S. January 9, 2020. REUTERS/George Frey 2/3 By Ahmed Aboulenein […]

Stock News

DoorDash Stock Surges as Results Beat Estimates, Analyst Praises ‘Industry-leading Execution’ By Investing.com

May 6, 2022 admin 0

© Reuters DoorDash (DASH) Stock Surges as Results Beat Estimates, Analyst Praises ‘Industry-leading Execution’ Shares of DoorDash Inc (NYSE:) are up more than 6% in premarket trading Friday after the food delivery company reported better-than-expected […]

Posts navigation

« 1 … 21,546 21,547 21,548 … 25,381 »

For Beginners


Categories

  • Forex News
  • Stock News
No Picture
Stock News

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

September 30, 2025 0

Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders

Stock News

Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary

September 30, 2025 0

Follow Summary The second quarter of 2025 was defined by several key policies from the new Trump administration, including tariffs/trade, immigration, and taxes. The fund returned 1.88% in the second quarter versus the ICE BoA […]

Latest news
  • Tesla (TSLA) Share Price Rises Ahead of Earnings Report
    September 30, 2025 0
  • Nikkei 225 Rises Following Resignation of Prime Minister Shigeru Ishiba
    September 8, 2025 0
Random News
  • Britain says EU will struggle to shift euro clearing from London By Reuters
    April 26, 2022 0
  • My International Portfolio: Another Abysmal Quarter Presenting Market Opportunities
    October 4, 2022 0
  • BTC/USD Faces 2021 Low as Risk Assets Plummet
    May 11, 2022 0
Email Inquiries to: warp1@sympatico.ca
  • No Picture
    Apellis Pharmaceuticals: Maintaining "Buy" Rating With Continued EMPAVELI Expansions Beyond PNH And C3G-Disorders
    September 30, 2025 0
  • Virtus Newfleet Multi-Sector Short Term Bond Fund Q2 2025 Commentary
    September 30, 2025 0
Pages
  • Contact Us
  • Home
  • Privacy Policy
  • Real Time Stock Update
  • Shop
  • Terms Of Service

© Copyright 2020-2023 Forex.ca

Please note that foreign exchange and other leveraged trading involves significant risk of loss. It is not suitable for all investors and you should make sure you understand the risks involved, seeking independent advice if necessary.